PortfoliosLab logo
UNH vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UNH and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

UNH vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UnitedHealth Group Incorporated (UNH) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%December2025FebruaryMarchAprilMay
804.13%
66.43%
UNH
PFE

Key characteristics

Sharpe Ratio

UNH:

-0.59

PFE:

-0.62

Sortino Ratio

UNH:

-0.50

PFE:

-0.58

Omega Ratio

UNH:

0.91

PFE:

0.93

Calmar Ratio

UNH:

-0.55

PFE:

-0.21

Martin Ratio

UNH:

-1.53

PFE:

-0.91

Ulcer Index

UNH:

13.53%

PFE:

13.28%

Daily Std Dev

UNH:

37.47%

PFE:

23.81%

Max Drawdown

UNH:

-82.68%

PFE:

-58.96%

Current Drawdown

UNH:

-37.84%

PFE:

-56.34%

Fundamentals

Market Cap

UNH:

$368.47B

PFE:

$134.92B

EPS

UNH:

$23.88

PFE:

$1.41

PE Ratio

UNH:

16.95

PFE:

16.87

PEG Ratio

UNH:

0.86

PFE:

0.61

PS Ratio

UNH:

0.90

PFE:

2.17

PB Ratio

UNH:

3.61

PFE:

1.56

Total Revenue (TTM)

UNH:

$407.42B

PFE:

$62.46B

Gross Profit (TTM)

UNH:

$87.53B

PFE:

$42.09B

EBITDA (TTM)

UNH:

$31.08B

PFE:

$16.71B

Returns By Period

In the year-to-date period, UNH achieves a -23.46% return, which is significantly lower than PFE's -11.99% return. Over the past 10 years, UNH has outperformed PFE with an annualized return of 14.66%, while PFE has yielded a comparatively lower 0.57% annualized return.


UNH

YTD

-23.46%

1M

-30.29%

6M

-35.80%

1Y

-22.16%

5Y*

7.68%

10Y*

14.66%

PFE

YTD

-11.99%

1M

5.17%

6M

-13.65%

1Y

-13.66%

5Y*

-4.28%

10Y*

0.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UNH vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UNH
The Risk-Adjusted Performance Rank of UNH is 1717
Overall Rank
The Sharpe Ratio Rank of UNH is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of UNH is 2424
Sortino Ratio Rank
The Omega Ratio Rank of UNH is 2020
Omega Ratio Rank
The Calmar Ratio Rank of UNH is 1717
Calmar Ratio Rank
The Martin Ratio Rank of UNH is 77
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2727
Overall Rank
The Sharpe Ratio Rank of PFE is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2222
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2424
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3939
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UNH vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for UnitedHealth Group Incorporated (UNH) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current UNH Sharpe Ratio is -0.59, which is comparable to the PFE Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of UNH and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00December2025FebruaryMarchAprilMay
-0.61
-0.62
UNH
PFE

Dividends

UNH vs. PFE - Dividend Comparison

UNH's dividend yield for the trailing twelve months is around 2.18%, less than PFE's 9.23% yield.


TTM20242023202220212020201920182017201620152014
UNH
UnitedHealth Group Incorporated
2.18%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%
PFE
Pfizer Inc.
9.23%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%

Drawdowns

UNH vs. PFE - Drawdown Comparison

The maximum UNH drawdown since its inception was -82.68%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for UNH and PFE. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-37.84%
-56.34%
UNH
PFE

Volatility

UNH vs. PFE - Volatility Comparison

UnitedHealth Group Incorporated (UNH) has a higher volatility of 26.06% compared to Pfizer Inc. (PFE) at 8.97%. This indicates that UNH's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
26.06%
8.97%
UNH
PFE

Financials

UNH vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between UnitedHealth Group Incorporated and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B20212022202320242025
109.58B
13.72B
(UNH) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

UNH vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between UnitedHealth Group Incorporated and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
21.7%
79.3%
(UNH) Gross Margin
(PFE) Gross Margin
UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a gross profit of 23.77B and revenue of 109.58B. Therefore, the gross margin over that period was 21.7%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported an operating income of 9.12B and revenue of 109.58B, resulting in an operating margin of 8.3%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a net income of 6.29B and revenue of 109.58B, resulting in a net margin of 5.7%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.